Sonia Gowda
Overview
Explore the profile of Sonia Gowda including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
42
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gowda S, Sandow L, Heinrich M
J Gastrointest Oncol
. 2024 May;
15(2):788-793.
PMID: 38756640
Background: Gastrointestinal stromal tumor (GIST) is a rare mesenchymal tumor arising in the gut, most commonly stomach or small bowel. The most common driver mutations are and which can be...
2.
Silbermann R, Schmidt T, Bal S, Dhakal B, Dholaria B, Biltibo E, et al.
EJHaem
. 2023 Aug;
4(3):775-778.
PMID: 37601885
Quadruplet induction, autologous hematopoietic cell transplant (AHCT), and measurable residual disease (MRD) response-adapted consolidation yield an unprecedented depth of response in newly diagnosed multiple myeloma. Patients treated on MASTER (NCT03224507)...
3.
Thawani R, Kartika T, Elstrott B, Batiuk E, Tao D, Gowda S, et al.
Thromb Res
. 2022 Jul;
217:12-14.
PMID: 35816991
No abstract available.
4.
McMurry H, Sabile J, Elstrott B, Chobrutskiy B, Mohinani A, Patel S, et al.
Thromb Res
. 2022 Jun;
216:1-7.
PMID: 35660708
Introduction: Splanchnic vein thrombosis (SVT) occurs in a heterogenous group of patients secondary to a variety of risk factors including liver disease. Minimal data regarding natural history and outcomes of...
5.
Goel A, Khorana A, Kartika T, Gowda S, Tao D, Thawani R, et al.
Eur J Haematol
. 2021 Dec;
108(4):271-277.
PMID: 34905252
Malignancy has long been implicated with hypercoagulability, leading to an increased rate of both venous and arterial thromboembolic events (VTE and ATE). Immunotherapy has established itself as a cornerstone of...
6.
Barisone G, ODonnell R, Ma Y, Abuhay M, Lundeberg K, Gowda S, et al.
PLoS One
. 2018 Jan;
13(1):e0190860.
PMID: 29304125
Non-Hodgkin lymphoma (NHL) affects over 400,000 people in the United States; its incidence increases with age. Treatment options are numerous and expanding, yet efficacy is often limited by toxicity, particularly...
7.
Arora M, Gowda S, Tuscano J
Ther Adv Hematol
. 2016 Aug;
7(4):209-21.
PMID: 27493711
Lenalidomide, an immunomodulatory drug that the US Food and Drug Administration (FDA) approved for the treatment of multiple myeloma, 5q- myelodysplasia and mantle-cell lymphoma (MCL), has encouraging efficacy in other...
8.